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SYSTEMS NEUROSCIENCE
While the GENSAT Drd1a-EGFP and Drd2-EGFP transgenic 
lines have been useful to study the physiology of striatopallidal and 
striatonigral MSNs, a recent study reports that that introduction 
of the BAC Drd2-EGFP transgene into the mouse genome may 
alter dopamine D2 receptor surface expression and cause aberrant 
locomotor behavior (Kramer et al., 2011). These findings raise the 
need for alternative methodologies to discriminate between these 
two populations of MSNs.
In a previous study, we evaluated the sensitivity and specific-
ity of using a single transgenic fluorescent reporter to properly 
identify both populations of striatal projection neurons (Shuen 
et al., 2008). Fluorescence intensity of a transgenic reporter can 
vary across lines, limiting the utility of certain lines for identifying 
all cells expressing the fluorescent reporter, especially when using 
techniques with relatively low sensitivity such as epifluorescence 
microscopy commonly found on electrophysiological rigs. The 
development of the Drd1a-tdTomato line 5 (Shuen et al., 2008) was 
a significant advancement over the existing Drd1a-EGFP line as 
the td-Tomato red fluorescent protein has a higher relative bright-
ness than EGFP (Deliolanis et al., 2008; Drobizhev et al., 2009) as 
well as a longer excitation wavelength which provides better tissue 
penetration. However, since its introduction, several characteristics 
that limit the robustness of the line 5 Drd1a-tdTomato transgenic 
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The development of BAC transgenic mice expressing promoter-specific fluorescent reporter 
proteins has been a great asset for neuroscience by enabling detection of neuronal subsets in 
live tissue. For the study of basal ganglia physiology, reporters driven by type 1 and 2 dopamine 
receptors have been particularly useful for distinguishing the two classes of striatal projection 
neurons – striatonigral and striatopallidal. However, emerging evidence suggests that some of 
the transgenic reporter lines may have suboptimal features. The ideal transgenic reporter line 
should (1) express a reporter with high sensitivity and specificity for detecting the cellular subset 
of interest and that does not otherwise alter the biology of the cells in which it is expressed, 
and (2) involve a genetic manipulation that does not cause any additional genetic effects other 
than expression of the reporter. Here we introduce a new BAC transgenic reporter line, Drd1a-
tdTomato line 6, with features that approximate these ideals, offering substantial benefits 
over existing lines. In this study, we investigate the integrity of dopamine-sensitive behaviors 
and test the sensitivity and specificity of tdTomato fluorescence for identifying striatonigral 
projection neurons in mice. Behaviorally, hemizygous Drd1a-tdTomato line 6 mice are similar to 
littermate controls; while hemizygous Drd2-EGFP mice are not. In characterizing the sensitivity 
and specificity of line 6 mice, we find that both are high. The results of this characterization 
indicate that line 6 Drd1a-tdTomato+/− mice offer a useful alternative approach to identify both 
striatonigral and striatopallidal neurons in a single transgenic line with a high degree of accuracy.
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doi: 10.3389/fnsys.2011.000325 cycles of 94°C for 30 s, 60–55°C touchdown ramp for 60 s and 
72°C for 90 s; 30 cycles of 94°C for 30 s, 55°C for 60 s and 72°C 
for 90 s followed by 1 cycle at 72°C for 5 min. PCR product 
length is approximately 800 bp. Genotyping of ChAT-EGFP was 
performed using the following primers: ChAT (forward) AGT 
AAG GCT ATG GGA TTC ATT C; ChAT (reverse) AGT TCA CCT 
TGA TGC CGT TC. The PCR protocol used is as follows: 1 cycle 
at 94°C for 3 min, 35 cycles of 94°C for 30 s, 52°C for 60 s and 
72°C for 60 s and 1 cycle of 72°C for 2 min. PCR product length 
is approximately 600 bp.
BehavIor
Mice aged 8–11 weeks were tested in the open field (OF) behavioral 
assay. Animals in their home cages were moved to the room where 
OF testing was performed at least 12 h prior to the experiment. For 
testing, animals were placed in OF chambers (21 × 21 × 30 cm) 
with clear polycarbonate walls. VersaMax Animal Activity Monitor 
(AccuScan Instruments, Columbus, OH, USA) was used to record 
behavioral response parameters including horizontal locomotion 
(distance in cm), counts of vertical movements, and stereotypies 
(repetitive beam breaks < 1 s apart). Location of mice was mapped 
and defined as being in either the center or perimeter zones (each 
10.5 cm2). Data was recorded in 5-min bins. Time-point values 
refer to total in each 5-min bin. OF data are reported during basal 
conditions (first 60 min in chamber) and following an injection 
of cocaine (20 mg/kg i.p.; minutes 61–180 in chamber). The loco-
motor response to cocaine was normalized to the mean distance 
traveled during the 20 min immediately preceding cocaine adminis-
tration (“baseline locomotion”). The genotype of the experimental 
subject was not known to the experimenter. Behavioral assays for 
each genotype were repeated in two separate cohorts. Transgene-
positive (+/−) and transgene-negative (−/−) mice for each genotype 
were compared using 2-way repeated measures ANOVA.
tIssue fIxatIon, ImmunostaInIng, and fluorescence ImagIng
Three-week-old mice were anesthetized with tribromoethanol 
(250 mg/kg i.p.) before transcardial perfusion with 4% para-
formaldehyde (PFA) in phosphate-buffered saline (PBS), pH 7.4. 
Brains were extracted and immersed in PFA solution for 24–72 h 
at 4°C prior to the sectioning of 50 μm slices on a Leica VTS-1000 
vibratome (Leica Microsystems, Bannockburn, IL, USA). Slices 
were transferred to 1X PBS for immunofluorescence staining of 
free floating sections except for slices prepared from line 6 Drd1a-
tdTomato+/−/ChAT-EGFP+/− mice which were directly mounted 
with Fluoromount-G mounting medium (Southern Biotech, 
Birmingham, AL, USA) without additional processing.
Slices were washed in PBS and incubated for 1 h in blocking buffer 
containing 5% bovine serum albumin, 2% normal goat serum, 
0.2% Triton X-100 in 1X PBS prior to immunostaining. Slices were 
incubated overnight at 4°C with the following primary antibod-
ies and dilutions: parvalbumin (PV) mouse monoclonal (P3088 
Sigma, St. Louis, MO, USA) 1:500, somatostatin (SS) rat monoclo-
nal (MAB354 Millipore, Billerica, MA 01821, USA) 1:50–1:100, and 
DARPP-32 rabbit polyclonal (AB1656 Millipore) 1:500. Secondary 
antibodies (Alexa Fluor-405 conjugated goat anti-mouse, Alexa 
Fluor-405 conjugated goat anti-rabbit, and Alexa Fluor-488 con-
jugated goat anti-mouse; all from Invitrogen, Carlsbad, CA, USA) 
line have been identified. Breeding experiments demonstrate an 
X-linked inheritance pattern . In addition, ambiguous mammary 
glands are more commonly observed on male mice in this line. A 
putative X-linked transgene also adds another level of care that 
users of this line need to apply in experimental subject breed-
ings in order to avoid inadvertently studying a biased population 
of only females in cases where the transgene donor is the father. 
Lastly, the fertility and litter-size of this transgenic line is severely 
reduced on a pure C57Bl/6 strain background. Because C57Bl/6 
is a commonly used strain in neuroscience, this further limits the 
utility of this line.
In this study, we characterize a second Drd1a-tdTomato BAC 
transgenic mouse line, line 6. We find that this line has normal 
fertility in the C57Bl/6 background, an autosomal-inheritance pat-
tern, no obvious morphological or cellular abnormalities, normal 
behavior in dopamine-sensitive motor tests, and high sensitivity 
and specificity of the fluorescent reporter for identifying striatoni-
gral MSNs. Altogether, these features overcome significant limita-
tions of existing transgenic lines and provide a useful option for 
accurate discrimination of both striatonigral and striatopallidal 
neurons using a single transgenic line.
materIals and methods
mIce
All animal procedures were done humanely to minimize distress and 
according to protocols approved by the Institutional Animal Care 
and Use Committee of Duke University. Mice used for behavioral 
experiments, Drd1a-tdTomato (line 6) and GENSAT Drd2-EGFP 
mice (courtesy of Drs. N. Heintz and X. W. Yang; provided to us 
from the Yang colony in 2006), were backcrossed onto a C57Bl/6 
background for a minimum of six generations. In behavioral experi-
ments, transgene-negative littermate controls (−/−) were compared 
to mice that were hemizygous for the transgene (+/−) of interest. 
Mice used for imaging experiments had hybrid strain backgrounds 
(sv129/FVB-1/C57Bl/6).  ChAT-EGFP mice [B6.Cg-Tg(RP23-
268L19-EGFP)2Mik/J] were obtained from The Jackson Laboratory 
(Bar Harbor, ME, USA). Mice used for electrophysiology experi-
ments were backcrossed onto a C57Bl/6 background. All mice 
were offspring of breeding pairs in which transgene expression 
was limited to one parent ensuring that all experimental animals 
were hemizygous for transgenes of interest. Line 6 Drd1a-tdTomato 
mice are available to the academic research community through The 
Jackson Laboratory (JAX stock number 16204).
genotypIng
Genotyping of Drd1a-tdTomato was performed using the follow-
ing primers: BGH-F (forward primer) 5-CTT CTG AGG CGG 
AAA GAA CC-3; dDR4 (reverse primer) 5-TTT CTG ATT GAG 
AGC ATT CG-3. The PCR protocol used is as follows: 1 cycle at 
94°C for 2 min, 5 cycles of 94°C for 30 s, 60–55°C touchdown 
ramp for 30 s and 72°C for 30 s; 25 cycles of 94°C for 30 s, 55°C 
for 30 s and 72°C for 30 s followed by 1 cycle at 72°C for 5 min. 
PCR product length is 846 bp. Genotyping of Drd2-EGFP was 
performed using the following primers: D2 (forward) CCC GAA 
GCT TCT CGA GGC GCG CCC TGT GCG TCA GCA TTT GGA 
GCA AC; GFPB2 (reverse) TCA GGG TCA GCT TGC CGT AGG5. 
The PCR protocol used is as follows: 1 cycle at 94°C for 2 min, 
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1 h prior to use. Standard ACSF contained (in mM): 124 NaCl, 2.5 KCl, 
1.2 NaH2PO4, 2 CaCl2, 1 MgCl2, 26 NaHCO3, and 10 D-(+)-glucose.
Recordings were obtained at room temperature (24–25°C) with 
continuous perfusion of standard ACSF at a rate of 2–3 ml/min. 
Whole-cell, patch-clamp recordings from MSNs in the dorsolateral 
striatum were performed. Cells were visualized with a 40× water-
immersion objective (LUMPlanFI, 40×/0.80 w) under an Olympus 
BX51WI microscope equipped with infrared differential interfer-
ence contrast optics, epifluorescence and an Olympus OLY-150 
camera/controller system (Olympus). Recording pipettes had a 
resistance of 2–3 MΩ when filled with internal pipette solution 
containing (in mM): 120 potassium gluconate, 20 KCl, 4 NaCl, 10 
HEPES, 0.2 EGTA, 4 MgATP, 0.3 Na2GTP and 10 sodium phospho-
creatine, pH 7.2–7.3 and ∼300 mOsm. No compensation was made 
for the liquid junction potential. Signals were amplified with an 
Axopatch 200B amplifier (Molecular Devices), digitally converted 
with a Digidata 1440A analog-to-digital converter (Molecular 
Devices), and stored on a computer for subsequent off-line analysis.
After establishing whole-cell configuration, cells were voltage 
clamped at −70 mV to check for series resistance (Rs). Cells with 
Rs < 20 MΩ were then held in I = 0 configuration and were allowed 
to equilibrate until the resting membrane potential (RMP) stabi-
lized (approximately 3–5 min). The RMP was recorded for 30 s and 
mean was reported. Current–voltage relationship experiments (to 
evaluate input resistance and action potential firing rate) were ini-
tiated with a membrane potential of −80 mV and consisted of a 
series of current injections (500 ms duration) between −200 and 
+400 pA in 25 pA delivered in step-wise increments. All current clamp 
recordings were sampled at 10 kHz and low-pass filtered at 2 kHz. 
Electrophysiological traces were analyzed offline using Clampfit 10.0 
(Molecular Devices). Rheobase for each cell was defined by the mini-
mal current that evoked action potentials. Graphic presentation and 
statistical comparison of data were performed using GraphPad Prism 
software (La Jolla, CA, USA). The mean RMP and the rheobase for 
each cell were compared statistically across cell types using unpaired 
Student’s t-tests. Two-way ANOVA was used to determine group 
effects of current injection and cell type on number of spikes and on 
membrane potential. Values are represented as mean ± SEM.
results
BehavIoral testIng
We first investigated the integrity of behaviors that are sensitive to 
dopamine signaling including general locomotor activity and the 
acute response to cocaine (Chandler et al., 1990; Karasinska et al., 
2005; Bateup et al., 2010). For these experiments, Drd1a-tdTomato 
line 6 mice were backcrossed for six generations to C57Bl/6 mice to 
minimize behavioral variability due to hybrid strain background. 
When we compared hemizygous (+/−) mice to transgene- negative 
littermates (−/−), we found that locomotor activity level was 
undisturbed in line 6 Drd1a-tdTomato+/− mice during OF testing 
(Figure 1A). In response to acute cocaine injection (20 mg/kg i.p.), 
we observed a greater than three-fold increase in locomotor activity 
relative to the pre-injection baseline period in mice of both geno-
types (Figure 1B). No differences in the acute locomotor response 
to cocaine were observed between line 6 Drd1a-tdTomato+/− and 
their transgene-negative littermate controls (Figure 1B).
were incubated at 1:800 dilutions. Cy5 conjugated donkey anti-rat 
antibodies were used at 1:200 dilution (Jackson ImmunoResearch 
Laboratories, Inc., Westgrove, PA, USA). Slices were mounted with 
Fluoromount-G mounting medium.
Sagittal slices were imaged on a Zeiss Axio Observer Z1 motor-
ized microscope equipped with a 10×/0.30 Plan-NeoFluar Ph1 
objective, X-CITE 120XL metal halide fluorescence light source, and 
Coolsnap ES2 high resolution CCD camera. TdTomato fluorescence 
was imaged with a red HQ45 filter cube (BP 560/40, FT 585, BP 
630/75). The low-magnification sagittal brain view (Figure 3A) is a 
composite image created by stitching together multiple 10× images 
using MetaMorph 7.6.5 software (Molecular Devices, Sunnyvale, 
CA, USA). Higher resolution images were acquired using a Zeiss 
LSM 510 inverted confocal microscope equipped with 405 nm 
Diode, Argon/2 (458, 477, 488, 514 nm), 561 nm Diode and HeNe 
633 nm lasers. Images were acquired using either 10×/0.30 NA 
(Plan Neo-Fluar) or 20×/0.80 NA (Plan Apochromat) objectives 
and acquisition software from Zeiss Microimaging (Thornwood, 
NY, USA). Confocal images were analyzed using ImageJ software 
(http://rsbweb.nih.gov/ij/).
Imaging of 300 μm thick acute coronal cortical–striatal slices 
was performed on an electrophysiological rig with continuous 
perfusion of standard artificial cerebrospinal fluid (ACSF). Slices 
were prepared using the procedure described for electrophysiol-
ogy recordings. Imaging was performed using a 60× water-immer-
sion objective (LUMPlanFL N, 60×/1.00 NA) under an Olympus 
BX51WI microscope equipped with phase contrast optics, epifluo-
rescence, an Olympus OLY-150 camera/controller system (Olympus 
America, Center Valley, PA, USA) and an HR-120 series mono-
chrome video monitor (DAGE-MTI, Michigan City, IN, USA). Cells 
within the dorsal striatum were first identified by phase-contrast 
illumination and then checked for fluorescence. Cells that appeared 
swollen or otherwise necrotic were not included in the analysis.
For both confocal and epifluorescent imaging data, the threshold 
for a positive signal was an intensity equal to or greater than that of 
the surrounding neuropil. Cells lacking transgene fluorescence were 
defined as those in which fluorescence was significantly lower than 
the surrounding neuropil (characteristic “black hole” appearance). 
Note: these criteria are different from those used in our previ-
ous study to characterize the Drd1a-tdTomato line 5 mice, which 
required fluorescence intensity to be greater than surrounding neu-
ropil to be considered positive (Shuen et al., 2008). To minimize 
light scattering effects which degrade imaging sensitivity, only cells 
in the first 60 μm of tissue depth were assessed.
acute slIce preparatIon and electrophysIology
For electrophysiological recordings, acute coronal brain slices 
(300 μm thick) were prepared from line 6 Drd1a-tdTomato+/−/Drd2-
EGFP+/− transgenic mice and their line 6 Drd1a-tdTomato−/−/Drd2-
EGFP+/− transgenic littermates (P21–27). Mice were anesthetized with 
tribromoethanol (250 mg/kg i.p.) and transcardially perfused with 
ice-cold sucrose ACSF oxygenated with 95% O2 and 5% CO2 prior 
to decapitation. Brains were rapidly removed and sectioned in oxy-
genated, ice-cold sucrose ACSF with a Vibratome 1500 (Vibratome, 
Bannockburn, IL, USA). Sucrose ACSF contained (in mM): 203 
sucrose, 2.5 KCl, 1.2 NaH2PO4, 0.5 CaCl2, 10 MgCl2, 23 NaHCO3, and 
10 D-(+)-glucose. Slices were maintained in standard ACSF saturated 
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cal rearing or time spent performing stereotypic movements, either 
basally or in response to acute cocaine (Figures 2A–D). While line 6 
mice showed no differences in the amount of time spent in the center 
region of the OF chamber (Figure 2E), Drd2-EGFP mice exhibited 
a statistically significant decrease in center time during basal activ-
ity (p = 0.013, Figure 2F). Neither line exhibited significant geno-
typic differences in center time during the response to acute cocaine 
injection (p = 0.187 for line 6 Drd1a-tdTomato and p = 0.535 for 
Drd2-EGFP, data not shown). Finally, transgene-positive mice were 
indistinguishable from their transgene-negative littermate controls 
based on gross morphological features and body weight (Drd1a-
tdTomato+/− 22.9 ± 1.1 g, n = 15; Drd1a-tdTomato−/− 22.0 ± 1.0 g, 
n = 14, p = 0.601; Drd2-EGFP+/− 19.8 ± 0.4 g, n = 17; Drd2-EGFP−/− 
20.3 ± 0.7 g, n = 15, p = 0.524). In summary, these behavioral data 
demonstrate normal behavior in line 6 Drd1a-tdTomato+/− mice. 
These data also support the recently reported claim that the Drd2-
EGFP transgene may induce phenotypic alterations.
specIfIcIty of tdtomato fluorescence
Within the dorsal striatum of Drd1a-tdTomato line 6 mice, we 
next investigated the specificity of tdTomato fluorescence for cor-
rectly assigning a fluorescent MSN to the striatonigral pathway. 
Basal locomotor behavior and acute locomotor response to 
cocaine were similarly tested in Drd2-EGFP transgenic mice. Drd2-
EGFP mice were first backcrossed to C57Bl/6 mice for six gen-
erations. Behavioral testing of Drd2-EGFP/ C57BL/6 served three 
purposes in these experiments. First, if abnormal, these results 
would serve as a positive control for our ability to detect abnor-
malities in these behavioral domains. Second, to our knowledge, 
these experiments report the locomotor response to acute cocaine 
in hemizygous Drd2-EGFP transgenic mice for the first time. Third, 
by comparing Drd2-EGFP+/− mice in a pure C57Bl/6 background 
with their transgene-negative littermates, these experiments test 
for the first time the effects of the transgene on behavior in the 
absence of confounding variables which arise when using cross-
strain behavioral controls. In contrast to line 6 mice, we found 
that basal locomotor activity during OF testing was significantly 
higher in hemizygous Drd2-EGFP mice as compared to their Drd2-
EGFP−/− littermates (p = 0.027, Figure 1C). Although hyperactive, 
no significant difference in the acute locomotor response to cocaine 
was observed (Figure 1D).
In addition to locomotor activity, other dopamine-dependent 
behavioral domains including vertical rearing, stereotypies and time 
spent in the center region of the OF chamber were assessed (Chandler 
et al., 1990; Tirelli and Witkin, 1994; Pogorelov et al., 2005). Neither 
Figure 1 | Basal locomotor activity and acute locomotor response to 
cocaine in Drd1a-tdTomato line 6 and Drd2-egFP BAC transgenic mice 
on C57Bl/6 background. (A) Basal horizontal locomotion of Drd1a-
tdTomato+/− line 6 mice (red, n = 14) is similar to transgene-negative 
(Drd1a-tdTomato−/−) littermates (black, n = 15; p = 0.515). (B) Acute cocaine 
administration (20 mg/kg i.p.) similarly increases horizontal locomotion in 
Drd1a-tdTomato+/− mice (red, n = 14) and Drd1a-tdTomato−/− littermates (black, 
n = 15; p = 0.945). Blue trace indicates response to vehicle control injection 
(n = 8 mice, 4 each of Drd1a-tdTomato−/− and Drd1a-tdTomato+/− mice. 
Responses were indistinguishable, so data were aggregated.) (C) Time 
course plots of basal horizontal locomotion demonstrate that Drd2-EGFP+/− 
mice (green, n = 17) are hyperactive compared to transgene-negative 
(Drd2-EGFP−/−) littermates (black, n = 15; p = 0.027). (D) Acute cocaine 
administration (20 mg/kg i.p.) induces a similar percent increase in locomotion 
in Drd2-EGFP+/− mice (green, n = 17) and Drd2-EGFP−/− littermates (black, 
n = 15; p = 0.616).
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immunolabeling (Anderson and Reiner, 1991; Ouimet et al., 1998) 
with detectable levels of both EGFP and tdTomato fluorescence 
were very rare (2.3% of 1095 DARPP-32 positive cells; Figure 3B).
Besides MSNs, interneurons of various types collectively rep-
resent approximately 5% of striatal neurons (see review by Tepper 
et al., 2010). Expression of tdTomato was investigated in the three 
most abundant interneuronal types – fast-spiking interneurons 
(FSIs), low-threshold spiking interneurons (LTS interneurons), 
and large tonically active aspiny cholinergic interneurons (TANs). 
PV immunostaining, to identify FSIs, failed to identify any FSIs 
with fluorescence from either the Drd1a-tdTomato (Figure 3C) 
or  Drd2-EGFP transgenes (0/52 PV-positive cells). Likewise, 
somatostatin immunostaining, to identify LTS interneurons, 
demonstrated that these cells do not contain detectable levels of 
fluorescence due to either the Drd1a-tdTomato (Figure 3D) or 
Drd2-EGFP transgenes (0/45 somatostatin-positive cells). TANs 
were visualized by EGFP fluorescence in ChAT-EGFP transgenic 
mice. No overlap was observed between tdTomato and EGFP 
fluorescence in slices prepared from Drd1a-tdTomato+/−/ChAT-
EGFP+/− mice (0/56 EGFP-fluorescent cells, Figure 3E). Lastly, 
astrocytes, as indicated by immunostaining with glial fibrillary 
acidic protein (GFAP), did not appreciably express tdTomato (0/37 
GFAP-positive cells, data not shown). In summary, these studies 
indicate that tdTomato fluorescence in dorsal striatal cells is highly 
specific to striatonigral MSNs.
sensItIvIty of tdtomato fluorescence
We next investigated whether tdTomato fluorescence also provided 
adequate sensitivity for detecting the majority of striatonigral 
MSNs. We addressed this question using two imaging approaches, 
confocal microscopy of thin fixed brain sections and epifluorescent 
microscopy of thicker acute brain slices (as commonly prepared for 
electrophysiological experiments), to define the upper and lower 
estimates of fluorescence detection sensitivity. In confocal imaging 
experiments, MSNs were defined by DARPP-32 immunostaining. 
In mice that were hemizygous for both Drd1a-tdTomato and Drd2-
EGFP transgenes, 8 of 1095 DARPP-32-positive cells (0.7%) did 
not have detectable fluorescence from either the tdTomato or EGFP 
reporter proteins (Figure 3B). This finding demonstrates that both 
transgenic reporters have negligible rates of false negativity for 
identifying MSNs under these imaging conditions (for details see 
Materials and Methods). We next examined the sensitivity of fluo-
rescence detection in MSNs under imaging conditions commonly 
used for identification of cells in live tissue during electrophysi-
ological experiments. In acute brain slices (300 μm thick), medium-
sized cells were first identified using phase-contrast illumination 
and then evaluated for fluorescence. Again, the vast majority of cells 
were accounted for by detectable fluorescence from the transgenic 
reporter proteins (518/544 cells; >95%, Figure 3B). These findings 
indicate that tdTomato fluorescence in line 6 mice can be highly 
sensitive and suitable for identifying all striatonigral MSNs.
IntegrIty of tdtomato-expressIng msns
We considered whether the ectopic expression of tdTomato pro-
teins in MSNs might alter cellular health (Vintersten et al., 2004; 
Long et al., 2005). We did not find evidence to support a toxic 
As expected for striatonigral MSNs, a low-magnification view of 
the brain from a Drd1a-tdTomato line 6 mouse demonstrates that 
fluorescent axonal projections from the striatum bypass the glo-
bus pallidus external (GPe) and terminate in the substantia nigra 
pars reticulata (SNr; Figure 3A). At the cellular level, we investi-
gated the extent to which tdTomato expression could be segregated 
from EGFP expression in Drd1a-tdTomato+/−/Drd2-EGFP+/− mice. 
In mice, the vast majority of striatal MSNs send axons through 
either the striatonigral or striatopallidal pathway, and these two 
populations of MSN projection neurons can be discriminated by 
expression of the type 1 and type 2 dopamine receptors, respectively 
(Gerfen et al., 1990). Thus, if the transgenes reliably identify these 
two populations, it is predicted that there should not be significant 
co-expression of the fluorescent reporters among striatal projection 
Figure 2 | Non-locomotor behaviors in line 6 Drd1a-tdTomato/C57Bl/6 
and Drd2-egFP/C57Bl/6 transgenic mice. Time course plots of the number 
of vertical movements basally and following acute cocaine injection (20 mg/kg 
i.p.) demonstrate that transgene-positive mice are similar to transgene-
negative littermate control mice in (A) Drd1a-tdTomato line 6 mice (Drd1a-
tdTomato+/−, red, n = 14; Drd1a-tdTomato−/−, black, n = 15; p = 0.778) and (B) 
Drd2-EGFP mice (Drd2-EGFP+/−, green, n = 17; Drd2-EGFP−/−, black, n = 15; 
p = 0.256). No differences in stereotypic movements basally and following 
acute cocaine injection were observed between transgene-positive and 
transgene-negative littermate control mice in (C) Drd1a-tdTomato line 6 mice 
(Drd1a-tdTomato+/−, red, n = 14; Drd1a-tdTomato−/−, black, n = 15; p = 0.615) 
and (D) Drd2-EGFP mice (Drd2-EGFP+/−, green, n = 17; Drd2-EGFP−/−, black, 
n = 15; p = 0.411). (e) Drd1a–tdTomato line 6 mice and transgene-negative 
littermate control mice spend a similar amount of time in center region of 
open field test chamber (Drd1a-tdTomato+/−, red, n = 14; Drd1a-tdTomato−/−, 
black, n = 15; p = 0.647). (F) Drd2-EGFP+/− (green, n = 17) spend significantly 
less time in the center region of the open field chamber compared to 
Drd2-EGFP−/− littermates (black, n = 15; p = 0.013).
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MSNs in the dorsal striatum. (A) A representative low-magnification sagittal 
view of tdTomato fluorescence of a brain slice from a hemizygous line 6 
Drd1a-tdTomato mouse demonstrating strong signal within striatal efferent 
axons terminating in substantia nigra pars reticulata (SNr) and negligible signal at 
the globus pallidus external (GPe). Abbreviations: cortex (Ctx), cerebellum (CB), 
dorsal striatum (DS) and nucleus accumbens (NAc). Scale bar represents 
500 μm. (B) Quantification of fluorescent signal detected in dorsal striatal cells 
from line 6 Drd1a-tdTomato+/−/Drd2-EGFP+/− mice. DARPP32+ cells were 
identified in immunohistochemically stained 50 μm thick brain sections (n = 605 
tdTomato only (red), 457 EGFP only (green), 25 dually labeled (red and green 
striped), and 8 non-fluorescent (gray) of 1095 total DARPP-32 immunopositive 
cells). Cells in acute 300 μm thick slices were identified by phase-contrast 
illumination. Fluorescent signals were detected using epifluorescence 
illumination (n = 293 tdTomato only (red), 230 EGFP only (green), 5 dually labeled 
(red and green striped), and 26 non-fluorescent (gray) of 549 total medium size 
cells identified by phase contrast illumination). (C) Representative confocal 
microscopy images demonstrating that cells immunopositive for the fast-spiking 
GABAergic interneuron marker, parvalbumin (PV), do not express tdTomato (0/52 
PV-immunopositive cells). (D) Representative confocal microscopy images 
demonstrating cells immunopositive for the low-threshold spiking GABAergic 
interneuron marker, somatostatin (SS), do not express tdTomato (0/45 
SS-immunopositive cells). (e) Representative confocal microscopy images 
demonstrating no overlap between tdTomato and EGFP fluorescence in line 6 
Drd1a-tdTomato+/−/ChAT-EGFP+/− mice (0/56 EGFP-positive cells). For panels 
(C–e), tdTomato fluorescence (left), interneuron antigen or transgenic reporter 
fluorescence (middle) and overlay of both signals (right). Scale bars represent 
25 μm.
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locomotor response to acute cocaine when compared to injection 
with saline. It is presently unclear if the genotype (hemi v. homo), 
strain background (C57Bl/6 v. hybrid) or other experimental design 
features are responsible for this difference. However, it is notable 
that, in the present study, we control for strain background, test 
only hemizygous mice, and use transgene-negative littermate con-
trols and still find that in two assays (basal levels of locomotion 
and time spent in center of test chamber) Drd2-EGFP transgenic 
animals have altered behavior. Thus, we provide further evidence 
that the Drd2-EGFP transgenic mouse line has unintended phe-
notypic disturbances.
Due to concerns about phenotypic abnormalities in the Drd2-
EGFP line, alternative methods to identify striatopallidal pathway 
neurons are desirable. The GENSAT A2A-EGFP mice (Gong et al., 
2003) provide one such alternative (Warre et al., 2011), although, 
effect resulting in the loss of striatonigral MSNs because the rela-
tive fraction of the total MSNs accounted for by tdTomato-positive 
neurons (57.9%, Figure 3B) was similar to what has been previ-
ously reported for striatonigral neurons (Bertran-Gonzalez et al., 
2008). To further test cellular integrity, we compared the physi-
ological properties of tdTomato-fluorescent neurons from Drd1a-
tdTomato+/−/Drd2-EGFP+/− mice to non-fluorescent neurons from 
Drd1a-tdTomato−/−/Drd2-EGFP+/−  littermate control mice. We 
found no significant differences in RMP, membrane input resist-
ance, rheobase or action potential firing rates (Figure 4).
dIscussIon
In this study, we characterize a new Drd1a-tdTomato BAC trans-
genic mouse line, line 6. Our results show that line 6 mice pro-
vide both high specificity and sensitivity for the identification of 
striatonigral (direct) pathway MSNs and offer several advantages 
over existing transgenic mouse lines that label striatal projection 
pathways. Foremost, recent concerns about phenotypic alteration 
of mice in a commonly used Drd2-EGFP transgenic line have raised 
a need to find alternative means for identifying direct and indirect 
pathway MSNs. Our results indicate that line 6 mice do not have 
phenotypic alterations and, if used under experimental conditions 
similar to those we report here, can be used as a single transgenic 
line to accurately assign MSNs to both pathways based on the pres-
ence or absence of fluorescence. Drd1a-tdTomato line 6 mice also 
offer the advantages that are afforded by (1) the brighter fluores-
cence of tdTomato in comparison to EGFP (Deliolanis et al., 2008; 
Drobizhev et al., 2009) and to line 5 Drd1a-tdTomato mice (data not 
shown), (2) an excitation wavelength which provides deeper tissue 
penetration (reduced scatter) than the excitation wavelength used 
for EGFP, (3) autosomal inheritance of the transgene, and (4) the 
ability to easily maintain on a C57Bl/6 background. Although the 
present study focuses on tdTomato expression in the dorsolateral 
striatum, representative images of other brain regions that may be 
of interest are provided (Figure 5).
In this study, we first investigated the behavioral integrity of 
line 6 mice and found no evidence for behavioral abnormalities in 
activity basally or in response to cocaine during OF testing. These 
results are similar to those reported for another line of transgenic 
mice that also contain the upstream regulatory elements for Drd1a, 
GENSAT Drd1a-EGFP mice (Kramer et al., 2011). Although the 
focus of our study was to characterize the new transgenic line, line 
6 Drd1a-tdTomato, we also provide new evidence that supports the 
findings by Alvarez and colleagues that Drd2-EGFP transgenic mice 
have altered behavioral phenotypes (Kramer et al., 2011). Both 
studies demonstrate increased basal locomotion in Drd2-EGFP 
mice, although to differing degrees. In this study, we found that 
hemizygous mice on a C57Bl/6 background exhibit approximately 
130% of littermate control activity levels. In the recent report by 
Alvarez and colleagues, homozygous mice on a hybrid background 
exhibited approximately 300% of Swiss Webster control activity 
levels (Kramer et al., 2011). Following acute cocaine challenge 
(20 mg/kg i.p.), we observed a robust increase in locomotor activ-
ity by hemizygous Drd2-EGFP/C57Bl/6 mice that was similar to 
littermate controls. The degree of acute cocaine-induced loco-
motor response we observe is consistent with prior observations 
in C57Bl/6 mice (Schlussman et al., 2003). Testing homozygous 
Figure 4 | expression of tdTomato reporter does not affect intrinsic 
membrane properties in striatonigral pathway MSNs. Whole-cell, current 
clamp recordings of striatonigral MSNs identified by tdTomato fluorescence in 
line 6 Drd1a-tdTomato+/−/Drd2-EGFP+/− mice (D1-Tom Fluor) or by lack of EGFP 
fluorescence in Drd1a-tdTomato−/−/Drd2-EGFP+/− littermates (D2-EGFP 
Non-Fluor) reveals no significant differences between the two groups. 
Representative responses from current clamp recordings in response to a 
series of current injections (25 pA increments) are shown for (A) a D1-Tom 
Fluor direct pathway MSN and (B) a D2-EGFP Non-Fluor direct pathway MSN. 
Summary graphs show D1-Tom Fluor MSNs (shown in black/closed circles, 
n = 12) and D2-EGFP Non-Fluor MSNs (shown in gray/open circles, n = 12) do 
not differ in (C) number of action potential spikes fired in response to 500-ms 
duration current injection steps, (D) rheobase, (e) current–voltage relationship/ 
input resistance or (F) resting membrane potential (RMP).
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Figure 5 | Survey of tdTomato expression in sagittal brain slices 
prepared from line 6 Drd1a-tdTomato+/− mice. Representative confocal 
images showing tdTomato expression at (A) the border between cortex and 
striatum (corpus callosum = CC), (B) the nucleus accumbens (NAc) and (C) 
the cerebellum (Purkinje cell = PC). (D) Representative epifluorescent image 
showing tdTomato expression in the hippocampus (dentate gyrus = DG). The 
contrast has been enhanced for each image to highlight tdTomato expression 
patterns within the subregion. Scale bars for all panels represent 100 μm.
behavioral characterization of these mice has not yet been reported. 
Another alternative is to use non-fluorescent cells in a line that 
reports direct pathway MSNs with high specificity and sensitivity. 
The results of the present study indicate that assignment of non-
fluorescent cells to the indirect pathway can be highly accurate in 
line 6 mice (Figure 3B). In mice expressing both the Drd2-EGFP 
and Drd1a-tdTomato transgenes, greater than 98% of MSNs lacking 
tdTomato fluorescence had detectable EGFP fluorescence under 
sensitive confocal imaging conditions. Under less sensitive condi-
tions (epifluorescent imaging and thicker acute brain slices), we 
still found that, among cells identified by phase contrast illumina-
tion, >90% of the cells lacking tdTomato fluorescence had EGFP 
fluorescence. Therefore, classifying indirect pathway MSNs solely 
by the absence of tdTomato fluorescence (without taking advan-
tage of additional means to define a cell as a MSN), one can still 
expect less than 10% contamination of indirect pathway data sets 
by type I errors. In reality, soma appearance and electrophysiologi-
cal characteristics are readily available to the electrophysiologist 
allowing them to restrict analyses to the subset of cells that are 
MSNs. We also characterized tdTomato fluorescence in striatal 
interneurons. Collectively, interneurons comprise approximately 
5% of total striatal neurons (Tepper et al., 2010). No tdTomato 
fluorescence was detected in the three most abundant striatal 
interneuron subtypes – tonically active cholinergic interneurons, 
fast-spiking GABAergic interneurons and low-threshold spiking 
interneurons. Other sparser interneuronal populations, such as 
calretinin positive GABArgic inteneurons and tyrosine hydroxy-
lase positive interneurons were not evaluated, and therefore, may 
express tdTomato. Finally, among a total of 2373 fluorescent cells 
from Drd1a-tdTomato+/−/Drd2-EGFP+/− mice, only 1.6% of cells 
expressed detectable levels of both fluorophores.
conclusIon
In summary, this study characterizes a new transgenic line that 
expresses tdTomato under the regulatory elements of the Drd1a 
gene. In the experiments reported herein, we found no evidence for 
changes in behavior or basic cellular properties due to transgene 
expression in Drd1a-tdTomato line 6 mice. Furthermore, the high 
selectivity and sensitivity of tdTomato fluorescence for reporting 
striatonigral MSNs in line 6 mice provides a reliable method for 
classifying both direct and indirect pathway neurons using a single 
transgenic mouse line.
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